Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal

Abstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.

Bibliographic Details
Main Authors: Namrata Singhania, Raman Al‐Odat, Anil K. Singh, Laith Al‐Rabadi
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.2695
_version_ 1818598742759047168
author Namrata Singhania
Raman Al‐Odat
Anil K. Singh
Laith Al‐Rabadi
author_facet Namrata Singhania
Raman Al‐Odat
Anil K. Singh
Laith Al‐Rabadi
author_sort Namrata Singhania
collection DOAJ
description Abstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.
first_indexed 2024-12-16T12:08:32Z
format Article
id doaj.art-2e84163f63374de38b2f6e12c0875ba3
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-12-16T12:08:32Z
publishDate 2020-04-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-2e84163f63374de38b2f6e12c0875ba32022-12-21T22:32:15ZengWileyClinical Case Reports2050-09042020-04-018472272410.1002/ccr3.2695Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoalNamrata Singhania0Raman Al‐Odat1Anil K. Singh2Laith Al‐Rabadi3Department of Hospital Medicine Mount Carmel East Hospital Columbus OhioDepartment of Internal Medicine University of New Mexico Albuquerque New MexicoDepartment of Internal Medicine Geisinger Community Medical Center Scranton PennsylvaniaDepartment of Nephrology University of Utah Salt Lake City UtahAbstract Development of acute abdominal pain after Kayexalate and activated charcoal administration should prompt clinician to consider intestinal necrosis. Concomitant use should be avoided to minimize the risk of this devastating but preventable condition.https://doi.org/10.1002/ccr3.2695activated charcoalend‐stage renal diseaseintentional drug overdosekayexalatekidney transplant
spellingShingle Namrata Singhania
Raman Al‐Odat
Anil K. Singh
Laith Al‐Rabadi
Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
Clinical Case Reports
activated charcoal
end‐stage renal disease
intentional drug overdose
kayexalate
kidney transplant
title Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
title_full Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
title_fullStr Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
title_full_unstemmed Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
title_short Intestinal necrosis after co‐administration of sodium polystyrene sulfonate and activated charcoal
title_sort intestinal necrosis after co administration of sodium polystyrene sulfonate and activated charcoal
topic activated charcoal
end‐stage renal disease
intentional drug overdose
kayexalate
kidney transplant
url https://doi.org/10.1002/ccr3.2695
work_keys_str_mv AT namratasinghania intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal
AT ramanalodat intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal
AT anilksingh intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal
AT laithalrabadi intestinalnecrosisaftercoadministrationofsodiumpolystyrenesulfonateandactivatedcharcoal